Results 151 to 160 of about 35,379 (241)
As implantable medical devices become indispensable to modern medicine, a silent threat grows alongside them: device‐associated infections. Despite decades of antibiotic innovation, infection rates keep climbing, costing lives and billions in healthcare expenses.
Benito Baldauf +5 more
wiley +1 more source
Paolo Fanzio,1,* Jason Hammer,1,* Nancy Van Laeken2,* 1Plastic Surgery & Regenerative Medicine, Allergan Aesthetics, an AbbVie Company, Irvine, CA, USA; 2Division of Plastic Surgery, University of British Columbia, Vancouver ...
Fanzio P, Hammer J, Van Laeken N
doaj
Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) in Breast Implants: A Case Report. [PDF]
Quiroz Diaz H +2 more
europepmc +1 more source
Anaplastic lymphoma associated with breast implants-Early diagnosis and treatment. [PDF]
de Paule CFP +8 more
europepmc +1 more source
Strategies to Improve the Lipophilicity of Hydrophilic Macromolecular Drugs
Hydrophilic macromolecular drugs can be successfully lipidized by covalent attachment of lipids, by hydrophobic ion pairing with negatively or positively charged surfactants, and by dry or wet reverse micelle formation. Lipophilicity enhancement of hydrophilic macromolecules has several benefits including stability and bioavailability improvement ...
Sera Lindner +8 more
wiley +1 more source
Worldwide Experience of Breast Implant-Associated Large Cell Lymphoma (BIA-ALCL): Expert Panel and Roundtable Discussion [PDF]
Jeffrey M. Kenkel +3 more
openalex +1 more source
Photosensitizing lipid nanoparticles (PLNPs) are engineered by incorporating cholesterol–PEG–pheophorbide a into MC3‐based LNPs and encapsulating GPX4‐targeting siRNA. Upon light activation, PLNPs generate reactive oxygen species (ROS) while silencing GPX4 to induce ferroptosis.
Ga‐Hyun Bae +9 more
wiley +1 more source
Epstein Barr Virus (EBV) positive large B-cell lymphoma associated with breast implants: A case report. [PDF]
Patarroyo LL, Vásquez FÁ, Farid Y.
europepmc +1 more source

